Arch Fam Med
Institution: CLOCKSS  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 3 No. 7, July 1994 TABLE OF CONTENTS
 • Online Features
  Original Contribution
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Giant Cell Arteritis

Corticosteroids, Temporal Artery Biopsy, and Blindness

David A. Weinberg, MD; Peter J. Savino, MD; Robert C. Sergott, MD; Thomas M. Bosley, MD

Arch Fam Med. 1994;3(7):623-627.

Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.

1. Wilson JD, Braunwald E, Isselbacher KJ, et al. Harrison's Principles of Internal Medicine. 12th ed. New York, NY: McGraw-Hill International Book Co; 1991: 1461-1462.
2. Keltner JL. Giant-cell arteritis. Ophthalmology. 1982;89:1101-1110. PUBMED
3. Hunder GG, Michet CJ. Giant cell arteritis and polymyalgia rheumatica. Clin Rheum Dis. 1985;11:471-483. PUBMED
4. Goodman BW. Temporal arteritis. Am J Med. 1979;67:839-852. PUBMED
5. Wagener HP, Hollenhorst RW. The ocular lesions of temporal arteritis. Am J Ophthalmol. 1958;45:617-630. PUBMED
6. Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis: a 25-year epidemiologic, clinical and pathologic study. Ann Intern Med. 1978;188:162-167.
7. Aiello PD, Trautmann JC, McPhee TJ, Kunselman AR, Hunder GG. Visual prognosis in giant cell arteritis. Ophthalmology. 1993;100:550-555. PUBMED
8. Gonzalez-Gay MA, Alonso MD, Aguero JJ, Bal M, Fernandez-Camblor B, Sanchez-Andrade AS. Temporal arteritis in a northwestern area of Spain: study of 57 biopsy-proven patients. J Rheumatol. 1992;19:277-280. PUBMED
9. McDonnell PJ, Moore GW, Miller NR, Hutchins GM, Green WR. Temporal arteritis: a clinicopathologic study. Ophthalmology. 1986;93:518-530. PUBMED
10. To KW, Enzer YR, Tsiaras WG. Temporal artery biopsy after one month of corticosteroid therapy. Am J Ophthalmol. 1994;117:265-267. PUBMED
11. Barton JJS, Corbett JJ. Neuro-ophthalmologic vascular emergencies in the elderly. Clin Geriatr Med. 1991;7:525-548. PUBMED
12. Burde RM, Savino PJ, Trobe JD. Clinical Decisions in Neuro-ophthalmology. 2nd ed. St Louis, Mo: Mosby—Year Book; 1992:51-56.
13. Graham E, Holland A, Avery A, Ross-Russell RW. Prognosis in giant cell arteritis. BMJ. 1981;282:269-271. FREE FULL TEXT
14. Rosenfeld SI, Kosmorsky GS, Klingele TG, Burde RM, Cohn EM. Treatment of temporal arteritis with ocular involvement. Am J Med. 1986;80:143-145. PUBMED
15. Hayreh SS. Anterior ischaemic optic neuropathy: differentiation of arteritic from nonarteritic type and its management. Eye. 1990;4:25-41. PUBMED
16. Matzkin DC, Slamovits TL, Sachs R, Burde RM. Visual recovery in two patients after intravenous methylprednisolone treatment of central retinal artery occlusion secondary to giant-cell arteritis. Ophthalmology. 1992;99:68-71. PUBMED
17. Jonasson F, Cullen JF, Elton RA. Temporal arteritis: a 14-year epidemiological, clinical and prognostic study. Scott Med J. 1979;11:111-119.
18. Beri M, Klugman MR, Kohler JA, Hayreh SS. Anterior ischemic optic neuropathy, VII: incidence of bilaterality and various influencing factors. Ophthalmology. 1987;94:1020-1028. PUBMED
19. Brownstein S, Nicolle DA, Codere F. Bilateral blindness in temporal arteritis with skip areas. Arch Ophthalmol. 1983;101:388-391. FREE FULL TEXT
20. Parsons-Smith G. Sudden blindness in cranial arteritis. Br J Ophthalmol. 1959;43:204-216. FREE FULL TEXT
21. Lipton RB, Solomon S, Wertenbaker C. Gradual loss and recovery of vision in temporal arteritis. Arch Intern Med. 1985;145:2252-2253. FREE FULL TEXT
22. Cullen JF, Coleiro J. Ophthalmic complications of giant cell arteritis: a review. Surv Ophthalmol. 1976;20:247-260. PUBMED
23. Delecoeuillerie G, Joly P, Cohen de Lara A, Paolaggi JB. Polymyalgia rheumatica and temporal arteritis: a retrospective analysis of prognostic features and different corticosteroid regimens (11-year survey of 210 patients). Ann Rheum Dis. 1988;47:733-739. FREE FULL TEXT
24. Kyle V, Hazleman BL. Treatment of polymyalgia rheumatica and giant cell arteritis, I: steroid regimens in the first two months. Ann Rheum Dis. 1989;48:658-661. FREE FULL TEXT
25. Lundberg I, Hedfors E. Restricted dose and duration of corticosteroid treatment in patients with polymyalgia rheumatica and temporal arteritis. J Rheumatol. 1990;17:1340-1345. PUBMED
26. Clearkin LG. IV steroids for central retinal artery occlusion in giant cell arteritis. Ophthalmology. 1992;99:1482-1483. PUBMED
27. Myles AB, Perera T, Ridley MG. Prevention of blindness in giant cell arteritis by corticosteroid treatment. Br J Rheumatol. 1992;31:103-105. FREE FULL TEXT
28. Diamond JP. IV steroid treatment of giant cell arteritis. Ophthalmology. 1993;100:291-292. PUBMED
29. Huston KA, Hunder GG. Giant cell (cranial) arteritis: a clinical review. Am Heart J. 1980;100:99-107. PUBMED
30. Diamond JP. Treatable blindness in temporal arteritis. Br J Ophthalmol. 1991;75:432. FREE FULL TEXT
31. Slamovits TL, Matzkin DC, Burde RM, Sachs R. Author's reply. Ophthalmology. 1992;99:1483-1484.
32. Cohen DN, Smith TR. Skip areas in temporal arteritis: myth versus fact. Trans Am Acad Ophthalmol Otolaryngol. 1974;78:772-783.
33. Albert DM, Ruchman MC, Keltner JL. Skip areas in temporal arteritis. Arch Ophthalmol. 1976;94:2072-2077. FREE FULL TEXT
34. Klein RG, Campbell RJ, Hunder GG, Carney JA. Skip lesions in temporal arteritis. Mayo Clin Proc. 1976;51:504-510. PUBMED
35. Glaser JS. Topical diagnosis: prechiasmal visual pathways. In: Tasman W, Jaeger EA, eds. Duane's Clinical Ophthalmology. Philadelphia, Pa: JB Lippincott; 1989;2:chap 5.
36. Barnes MP, Bateman DE, Cleland PG, et al. Intravenous methylprednisolone for multiple sclerosis in relapse. J Neurol Neurosurg Psychiatry. 1985;48:157-159. FREE FULL TEXT
37. Wakefield D, McCluskey P, Penny R. Intravenous pulse methylprednisolone therapy in severe inflammatory eye disease. Arch Ophthalmol. 1986;104:847-851. FREE FULL TEXT
38. McCluskey P, Wakefield D. Intravenous pulse methylprednisolone in scleritis. Arch Ophthalmol. 1987;105:793-797. FREE FULL TEXT
39. Milligan NM, Newcombe R, Compston DAS. A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis, I: clinical effects. J Neurol Neurosurg Psychiatry. 1987;50:511-516. FREE FULL TEXT
40. Lyons PR, Newman PK, Saunders M. Methylprednisolone therapy in multiple sclerosis: a profile of adverse effects. J Neurol Neurosurg Psychiatry. 1988;51:285-287. FREE FULL TEXT
41. Radia M, Furst DE. Comparison of three pulse methylprednisolone regimens in the treatment of rheumatoid arthritis. J Rheumatol. 1988;15:242-246. PUBMED
42. Spoor TC, Rockwell DL. Treatment of optic neuritis with intravenous megadose corticosteroids: a consecutive series. Ophthalmology. 1988;95:131-134. PUBMED
43. Chrousos GA, Kattah JC, Beck RW, Cleary PA, the Optic Neuritis Study Group. Side effects of glucocorticoid treatment: experience of the Optic Neuritis Treatment Trial. JAMA. 1993;269:2110-2112. FREE FULL TEXT